Clearmind Medicine (CMND) Stock Soars Thursday: What's Going On?

Evette Mitkov

November 13, 2025

Clearmind Medicine Inc (NASDAQ:CMND) shares are trading higher on Thursday. The company reported that Hadassah Medical Center in Jerusalem has given its final approval for an ongoing Phase 1/2a clinical trial, which is assessing CMND-100’s potential to treat alcohol use disorder (AUD).

CMND is delivering impressive returns. See what is driving the move here.

What To Know: The clinical-stage biotech company’s CMND-100 is a proprietary MEAI-based oral drug candidate. Clearmind received final approval for its ongoing Phase 1/2a clinical trial evaluating CMND-100 for the treatment of AUD.

The first cohort treatment of Clearmind’s clinical trial was successfully completed. The approval enables Hadassah Medical Center to join the company’s clinical trial.

The Yale School of Medicine’s Department of Psychiatry, Johns Hopkins University School of Medicine, and Israel’s Tel Aviv Sourasky Medical Center are among the other institutions taking part in the trial. The study at Hadassah-University Medical Center will be supervised by Joseph Caraco, the director of the clinical pharmacology unit in the medical department.

The Phase 1/2a clinical trial is a multinational, multi-center investigation intended to assess the pharmacokinetic profile, safety and tolerability of CMND-100. Additionally, the study will gauge its initial success in lowering alcohol consumption and cravings in patients with alcohol use disorder.

According to the World Health Organization, AUD causes 4.7% of all deaths globally; Clearmind’s trial aims to address this issue. With the goal of providing a ground-breaking solution for those impacted by AUD and their families, the company expects to make additional steps in patient enrollment and data collection throughout its clinical site.

CMND Price Action: Clearmind shares were up 18.05%, trading at approximately 37 cents at the time of publication on Thursday, according to Benzinga Pro. Operating in the pharmaceutical industry, Clearmind Medicine’s 52-week range shows notable volatility, peaking at $2.18, indicating a high level of investor speculation or interest in the company’s potential for growth.

Read Next:

Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

Image: Bigc Studio/Shutterstock.com

Recommended

The New Gold Trade Dominating on Wall Street - Ad

Why Wall Street Is Piling Into the "Debasement Trade" - Ad

America's Next Security Revolution Has Begun - Ad

The new ETFs offer 2x exposure to Bloom Energy, Celestica, NANO Nuclear Energy, and Synopsys—each linked to America's expanding AI infrastructure.

Why Airlines May Hold Pricing Power Into 2026 Even After Shutdown Disruptions

BofA Securities says US airlines are strong despite shutdown, with core demand drivers and capacity discipline supporting positive outlook.

Another Gold High? Here's the Move Wall Street Is Missing ...

Another Gold High? Here's the Move Wall Street Is Missing ... - Ad

Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.

Home Depot Could Hammer Out Gains With Pro Expansion, Analyst Says

Bank of America expects Home Depot's Q3 earnings to show 1.3% sales increase. Analysts maintain Buy rating and $450 price forecast.

Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial

Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.

A Low-Profile Memecoin Is Quietly Gaining Serious Momentum

A Low-Profile Memecoin Is Quietly Gaining Serious Momentum - Ad

While everyone's watching the big-name coins, a lesser-known memecoin is gathering speed. With unique utility, a growing user base, and strong chart signals, our research team believes this could be a breakout waiting to happen.

Nasdaq 100 Faces Worst November Since 2008 As AI Boom Hits A Wall

The Nasdaq 100 is breaking its bullish November streak as AI infrastructure bottlenecks, led by CoreWeave, shake up 2025 tech market performance.

Marjorie Taylor Greene Buys Blue Chip Stock Near 52-Week Low

Marjorie Taylor Greene is known for buying multiple stocks at a time, based on recent disclosures. A new filing shows one stock bought in November.

This Overlooked Memecoin Is Showing Early Breakout Signals

This Overlooked Memecoin Is Showing Early Breakout Signals - Ad

We've been tracking one small memecoin that checks all the boxes: strong on-chain signals, real traction, and an entry point that could offer serious upside. It's not on many radars yet-but that could change fast.

Job Market Pessimism Among Americans Hovers At Record Highs: 'Fears of Unemployment Have Never Been This Elevated'

Job market pessimism among Americans has reached alarming levels, with a dramatic surge in fears about unemployment and job security in recent weeks.

Congress Ended The Shutdown — But At The Cost Of Re-Criminalizing These THC Products In A Last-Minute Deal That Could Reshape The Cannabis Industry

Congress appears set to end the record-long government shutdown, but a controversial provision tucked into the spending bill is sparking alarm across the hemp and cannabis industry.

"Tech Prophet" Who Predicted the iPhone Now Predicts...

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

MSNBC's name is being replaced, but its leaders insist that its mission will remain the same

NEW YORK (AP) — Asked what viewers should expect when television's MSNBC makes its from NBC News final this weekend, network president Rebecca Kutler points to a poster on the wall of a conference room at its new offices off Times Square.

The Real Reason This Analyst Still Calls Nebius His Favorite Neocloud Player

Nebius Group (NASDAQ: NBIS) reported strong Q3 results, boosting capacity & revenue guidance through 2026. Analyst reiterated Buy rating.

Buy This Stock Tomorrow?

Buy This Stock Tomorrow? - Ad

A renowned former hedge fund manager - friends to some of the biggest investors in the world - just released a new list of his favorite AI stocks... and not a single Magnificent 7 name made the cut. Instead, an AI stock you've likely never heard of just flagged as "near-perfect" in his new investing scoring system.

Trump administration and private investors sign off on $1.4 billion deal with rare earth startups

WASHINGTON (AP) — The Trump administration and private investors are partnering with two rare earth startups in a $1.4 billion deal to scale up the nation's access to materials and technology that is crucial for producing an array of high-tech goods and military equipment.

From beaches to ski slopes, photos show how cameras keep watch all over China

BEIJING, China (AP) —

The K7 Is Changing the Economics of Security

The K7 Is Changing the Economics of Security - Ad

$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.

Opendoor Stock Gains Ground: What's Behind The Recent Momentum?

Opendoor Technologies Inc (NASDAQ:OPEN) shares are trading higher on Wednesday. Here's what you need to know.

Jim Cramer: Chipotle Is 'Too Expensive,' Buy This Plane Maker

On "Mad Money," Cramer discusses Henry Schein, Bloom Energy, Tyler Technologies, Boeing and Chipotle Mexican Grill.

After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough

After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad

For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.

Meta Stock Continues To Slide: What's Going On?

Meta Platforms Inc (NASDAQ:META) shares are trading lower on Wednesday. Here's everything you need to know.

Cathie Wood Dumps $30 Million Worth Of Tesla Stock Amid China Sales Slump, Loads Up Circle And This Hot Chinese AI Stock

On Wednesday, Cathie Wood-led Ark Invest executed significant trades involving Circle Internet Group Inc. (NYSE:CRCL), Alibaba Group Holding Ltd.

The New Gold Trade Dominating on Wall Street

The New Gold Trade Dominating on Wall Street - Ad

Wall Street has been making headlines lately for piling into gold. According to Dr. David Eifrig, the gold bull run is just getting started. He says you should move your money to his No. 1 gold stock immediately (not a miner or ETF but it has 1,000% upside potential.)

Tesla's First Semi Vehicle Customer After Full Production Launch Is….Tesla?

Tesla Semi is one of several vehicles set for full-scale production in 2026 from Tesla. Here's the company's first major customer.

Traders Love This Time Of Year For Broadcom — Here's Why It Rarely Fails

Broadcom stock has gained in 14 of the last 16 mid-November to mid-December periods, with an average return of 8.9%.

Why Wall Street Is Piling Into the "Debasement Trade"

Why Wall Street Is Piling Into the "Debasement Trade" - Ad

Wall Street has been making headlines lately for piling into a strange new money move. What they've dubbed the "Debasement Trade"... And it could affect you and your money in a MAJOR way. Dr. David Eifrig's latest warning deserves your attention.

FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical

The U.S. Food and Drug Administration says drugmakers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.

A medley of tech gifts for everyone on your holiday shopping list

NEW YORK (AP) — It's the most wonderful time of the year, unless you want to find the perfect gifts for .

America's Next Security Revolution Has Begun

America's Next Security Revolution Has Begun - Ad

Built for endurance, powered by AI, and proven in the field, the K7 is redefining protection for ports, energy hubs, and cities across the nation. The rollout is already underway.

Dave Ramsey Reveals Why Millionaires Crush Mortgages Early

Dave Ramsey advises buying a home with cash, citing his firm's survey of millionaires who often retire their mortgages in about 10 years.

Cathie Wood Goes Big On Alibaba With $25 Million Share Purchase, Scales Back On This Social Media Stock

Ark Invest made big moves in its portfolio, focusing on Alibaba, Baidu, and Reddit amid evolving market dynamics and regulatory challenges.

Another Gold High? Here's the Move Wall Street Is Missing ...

Another Gold High? Here's the Move Wall Street Is Missing ... - Ad

Transportation Secretary Sean Duffy warns of 'mass chaos' in skies if shutdown continues

Transportation Secretary Sean Duffy predicted Tuesday that there could be chaos in the skies next week if the government shutdown drags on and air traffic controllers miss a second paycheck.

Nearly 8 Million Shiba Inu Vanish After First SHIB ETF Filing Shakes Market

Nearly 8 million Shiba Inu (CRYPTO: SHIB) tokens have been incinerated following the inaugural filing of a Shiba Inu ETF, rekindling interest in the popular meme token.

A Low-Profile Memecoin Is Quietly Gaining Serious Momentum

A Low-Profile Memecoin Is Quietly Gaining Serious Momentum - Ad

Nvidia Packaging Partner Amkor Logs Momentum Gain— Up Over 30% YTD On AI Surge

Amkor Technologies (AMKR) hits top momentum percentile, up over 30% YTD as Nvidia's key CoWoS/HBM partner. AI surge drives gains.

Sam Altman Says 'Shame on Me' If OpenAI Doesn't Become 'First Big Company' Run By An AI CEO

Sam Altman, the CEO of OpenAI, has made a bold prediction about the future of the company.

This Overlooked Memecoin Is Showing Early Breakout Signals

This Overlooked Memecoin Is Showing Early Breakout Signals - Ad

Bitcoin, Ethereum, XRP, Dogecoin Dip As Fed Chair Powell Pours Cold Water On December Rate Cut Hopes: Analyst Says Watch Out For These Key BTC Levels

Leading cryptocurrencies fell alongside major stock indexes on Wednesday as Federal Reserve Chair Jerome Powell said that a year-end interest rate cut is “not a foregone conclusion.”

Trending Now